Endo Health Solutions Inc

Pro

The StockScouter measure of relative price change and consistency is very high. Very positive

One or more analysts has modestly increased quarterly earnings estimates for ENDP. Positive

Con

The price-to-earnings multiple is a negative number. No effect

Shares are being heavily sold by financial institutions. Neutral for a large company like ENDP

The most recent quarterly earnings report was approximately equal to or higher than analysts’ consensus forecast, but not to a degree that is predictive of future returns. Neutral

Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative

One or more analysts has modestly increased quarterly earnings estimates for ENDP. Positive

Two or more executives, directors or major shareholders sold a large number of shares recently. Very negative

Shares are being heavily sold by financial institutions. Neutral for a large company like ENDP

The price-to-earnings multiple is a negative number. No effect

The price-to-sales multiple is about the same as the average for all stocks in the StockScouter universe. Neutral for a medium- to large-sized company like ENDP

The ratio of ENDP's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.

The StockScouter measure of relative price change and consistency is very high. Very positive

Previous day's closing price for ENDP was slightly above its 50-day moving average. Positive